Joshua Gruber

机构：Gilead Sciences (United States)

发表论文 25 篇 · 总被引 40 次 · h-index 4

代表论文

• Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis B (2025 · AIDS · 被引 9)
• Persistence in treatment-experienced people with HIV switching anti-retroviral therapy regimens since 2018 (2024 · Future Virology · 被引 8)
• Health care provider– and patient-reported outcomes for bictegravir/emtricitabine/tenofovir alafenamide versus other antiretroviral regimens: an observational survey in the United States (July 2021–March 2022) (2025 · Current Medical Research and Opinion · 被引 5)
• Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study (2025 · Open Forum Infectious Diseases · 被引 4)
• Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruption (2025 · AIDS · 被引 3)
• Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018 (2024 · Journal of Managed Care & Specialty Pharmacy · 被引 3)